Study on the complement-dependent cytotoxic effect of the sera of hamsters bearing transplanted melanoma. 1985

K Kozłowska, and B Zurawska-Czupa, and A Kostulak

Complement-dependent cytotoxic effect of the sera of hamsters bearing transplanted melanomas: melanotic and amelanotic, was examined in relation to isolated melanocytes of these melanomas. A specific, cytotoxic effect, ranging 34-47% of the sera of hamsters with both types of melanomas in relation to the cells of these tumors was found. No relationship between the biological properties of melanoma and cytotoxic activity of serum was noted.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008647 Mesocricetus A genus in the order Rodentia and family Cricetidae. One species, Mesocricetus auratus or golden hamster is widely used in biomedical research. Hamsters, Golden,Hamsters, Golden Syrian,Hamsters, Syrian,Mesocricetus auratus,Syrian Golden Hamster,Syrian Hamster,Golden Hamster,Golden Hamster, Syrian,Golden Hamsters,Golden Syrian Hamsters,Hamster, Golden,Hamster, Syrian,Hamster, Syrian Golden,Syrian Hamsters
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor

Related Publications

K Kozłowska, and B Zurawska-Czupa, and A Kostulak
January 1980, Neoplasma,
K Kozłowska, and B Zurawska-Czupa, and A Kostulak
August 1975, European journal of immunology,
K Kozłowska, and B Zurawska-Czupa, and A Kostulak
June 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K Kozłowska, and B Zurawska-Czupa, and A Kostulak
March 1980, Cancer research,
K Kozłowska, and B Zurawska-Czupa, and A Kostulak
January 1997, Biotherapy (Dordrecht, Netherlands),
K Kozłowska, and B Zurawska-Czupa, and A Kostulak
January 1959, Comptes rendus des seances de la Societe de biologie et de ses filiales,
K Kozłowska, and B Zurawska-Czupa, and A Kostulak
January 1966, Wakayama medical reports,
K Kozłowska, and B Zurawska-Czupa, and A Kostulak
June 1989, Nihon Gan Chiryo Gakkai shi,
K Kozłowska, and B Zurawska-Czupa, and A Kostulak
May 1977, Journal of the National Cancer Institute,
Copied contents to your clipboard!